Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
six
months ended in Dec. 2025,
China Resources Medical Holdings Co paid$0 Mil more to buy back shares than it received from issuing new shares.
It spent$100 Mil paying down its debt.
It paid$0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It received$0 Mil from paying cash dividends to shareholders.
It spent$28 Mil on other financial activities.
In all, China Resources Medical Holdings Cospent$128 Mil on financial activities for the
six
months ended in Dec. 2025.
China Resources Medical Holdings Co (OTCPK:CMHDF) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
China Resources Medical Holdings Co's issuance of stock for the
six
months ended in Dec. 2025 was $0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
China Resources Medical Holdings Co's repurchase of stock for the
six
months ended in Dec. 2025 was $0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
China Resources Medical Holdings Co's net issuance of debt for the
six
months ended in Dec. 2025 was $-100 Mil.
China Resources Medical Holdings Co spent$100 Mil paying down its debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
China Resources Medical Holdings Co's net issuance of preferred for the
six
months ended in Dec. 2025 was $0 Mil.
China Resources Medical Holdings Co paid$0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
China Resources Medical Holdings Co's cash flow for dividends for the
six
months ended in Dec. 2025 was $0 Mil.
China Resources Medical Holdings Co received$0 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
China Resources Medical Holdings Co's other financing for the
six
months ended in Dec. 2025 was $-28 Mil.
China Resources Medical Holdings Co spent$28 Mil on other financial activities.
China Resources Medical Holdings Co Cash Flow from Financing Related Terms
China Resources Medical Holdings Co Cash Flow from Financing Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Medical Holdings Co Cash Flow from Financing Chart
China Resources Medical Holdings Co Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-152 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of $-152 Mil mean?
China Resources Medical Holdings Co (CMHDF) has a Cash Flow from Financing of $-152 Mil as of Dec. 2025. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for China Resources Medical Holdings Co and its competitors.
Is China Resources Medical Holdings Co's Cash Flow from Financing too high?
China Resources Medical Holdings Co's current Cash Flow from Financing is $-152 Mil. Overall, China Resources Medical Holdings Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does China Resources Medical Holdings Co's Cash Flow from Financing compare to HCA and THC?
China Resources Medical Holdings Co's Cash Flow from Financing of $-152 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Healthcare Providers & Services company?
A good Cash Flow from Financing depends on the Healthcare Providers & Services industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for China Resources Medical Holdings Co and its competitors. China Resources Medical Holdings Co's current Cash Flow from Financing is $-152 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Medical Holdings Co stock overvalued right now?
China Resources Medical Holdings Co (CMHDF) has a current Cash Flow from Financing of $-152 Mil. The stock's GF Value™ is $0.94, compared to a current price of $0.58 — trading 38.3% below its estimated fair value. The current Cash Flow from Financing is $-152 Mil. China Resources Medical Holdings Co's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For China Resources Medical Holdings Co (CMHDF), the current Cash Flow from Financing is $-152 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Resources Medical Holdings Co (CMHDF) Overvalued in 2026?
Based on GuruFocus' analysis, China Resources Medical Holdings Co stock appears to be undervalued.
The current stock price of $0.58 is trading 38.3% below its estimated GF Value™ of $0.94.
Key valuation signals for CMHDF:
Cash Flow from Financing: $-152 Mil
GF Value™: $0.94 vs. price of $0.58 (38.3% below fair value)
No single metric tells the full story. See the CMHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Resources Medical Holdings Co Business Description
China Resources Medical Holdings Co Ltd is engaged in the provision of general healthcare services; provision of hospital management services, sale of pharmaceuticals, medical devices, and medical consumables, and provision of other services in the Chinese Mainland. The group has two operating segments: Hospital Business and Other Business. The Hospital Business segment includes outpatient business and inpatient business corresponding to self-owned hospitals. The Other business segment includes operation management services, supply chain services, and other ancillary services provided to participating hospitals and IOT/OT hospitals. It generates the majority of its revenue from the Hospital Business segment.
88GF Score
Get the complete analysis for CMHDF
Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CMHDF has been successfully added to your 
